Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Costagliola D

Collect these papers and discover other ones on Labmeeting. Learn more.

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

+ cite this

+ View Abstract

Moore DM, Harris R, Lima V, Hogg B, May M, Yip B, Justice A, Mocroft A, Reiss P, Lampe F, Chêne G, Costagliola D, Elzi L, Mugavero MJ, Monforte AD, Sabin C,

(show remaining authors)

Journal of acquired immune deficiency syndromes (1999) 52(3):357-63, 2009 Nov 1 - Who cited this? | PubMed ID: 19668084 | Fulltext

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005.

+ cite this

+ View Abstract

Potard V, Weiss L, Lamontagne F, Rouveix E, Beck-Wirth G, Drogoul-Vey MP, Souala MF, Costagliola D, and French Hospital Database on HIV ANRS CO4

Journal of acquired immune deficiency syndromes (1999) 52(3):422-6, 2009 Nov 1 - Who cited this? | PubMed ID: 19521249 | Fulltext

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

+ cite this

Lièvre M, Members of the Epidemiology Working Group of the French Pharmacovigilance Commission, Costagliola D, Evans S, Fourrier A, Imbs JL, Levy-Bruhl D, Merle L, Micallef J, and Oger E

Neurology 73(17):1426-7, 2009 Oct 27 - Who cited this? | PubMed ID: 19858469 | Fulltext

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

+ cite this

+ View Abstract

antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M,

(show remaining authors)

AIDS (London, England) 23(16):2199-208, 2009 Oct 23 - Who cited this? | PubMed ID: 19779320 | Fulltext

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.

+ cite this

+ View Abstract

Mounier N, Katlama C, Costagliola D, Chichmanian RM, and Spano JP

Critical reviews in oncology/hematology 72(1):10-20, 2009 Oct - Who cited this? | PubMed ID: 19070506 | Fulltext

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.

+ cite this

+ View Abstract

Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N, Costagliola D, Le Bras J, Matheron S, and FHDH-ANRS CO4 Clinical Epidemiology Group

AIDS (London, England) 23(15):1997-2004, 2009 Sep 24 - Who cited this? | PubMed ID: 19654499 | Fulltext

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

+ cite this

+ View Abstract

Marin B, Thiébaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, Hamouda O, Prins M, Walker S, Porter K, Sabin C, and Chêne G

AIDS (London, England) 23(13):1743-53, 2009 Aug 24 - Who cited this? | PubMed ID: 19571723 | Fulltext

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.

+ cite this

+ View Abstract

Soulié C, Assoumou L, Ghosn J, Duvivier C, Peytavin G, Ait-Arkoub Z, Molina JM, Costagliola D, Katlama C, Calvez V, and Marcelin AG

AIDS (London, England) 23(12):1605-8, 2009 Jul 31 - Who cited this? | PubMed ID: 19487903 | Fulltext

A step ahead on the HIV collaboratory.

+ cite this

Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ,

(show remaining authors)

Science (New York, N.Y.) 324(5932):1264-5, 2009 Jun 5 - Who cited this? | PubMed ID: 19498149 | Fulltext

Environmental genomics: a tale of two fishes.

+ cite this

+ View Abstract

Bucciarelli G, Di Filippo M, Costagliola D, Alvarez-Valin F, Bernardi G, and Bernardi G

Molecular biology and evolution 26(6):1235-43, 2009 Jun - Who cited this? | PubMed ID: 19270014 | Fulltext

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.

+ cite this

+ View Abstract

Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, and Costagliola D

AIDS (London, England) 23(9):1163-9, 2009 Jun 1 - Who cited this? | PubMed ID: 19444075 | Fulltext

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

+ cite this

+ View Abstract

Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P, and Mortavic/Mortalité 2005 Study Group

HIV medicine 10(5):282-9, 2009 May - Who cited this? | PubMed ID: 19226410 | Fulltext

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

+ cite this

+ View Abstract

Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D, and ANRS 121 Hippocampe study group

AIDS (London, England) 27(7):817-24, 2009 Apr 27 - Who cited this? | PubMed ID: 19363330 | Fulltext

How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates.

+ cite this

+ View Abstract

Lanoy E, Lewden C, Lièvre L, Tattevin P, Boileau J, Aouba A, Chêne G, Costagliola D, Clinical Epidemiologic Group of the French Hospital Database on HIV (ANRS CO4 FHDH), and Groupe d'Etude Mortalité 2000

HIV medicine 10(4):236-45, 2009 Apr - Who cited this? | PubMed ID: 19178591 | Fulltext

Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.

+ cite this

+ View Abstract

Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Cacoub P, Chêne G, and ANRS EN19 Mortalité Study Group and Mortavic

Journal of hepatology 50(4):736-45, 2009 Apr - Who cited this? | PubMed ID: 19231018 | Fulltext

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

+ cite this

+ View Abstract

Chaix ML, Descamps D, Wirden M, Bocket L, Delaugerre C, Tamalet C, Schneider V, Izopet J, Masquelier B, Rouzioux C, Meyer L, Costagliola D, ANRS AC11 Resistance Group, Cohort PRIMO ANRS CO 6, and FHDH ANRS CO4 Study Groups

AIDS (London, England) 23(6):717-24, 2009 Mar 27 - Who cited this? | PubMed ID: 19279445 | Fulltext

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

+ cite this

+ View Abstract

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P, Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group, and Mortavic Study Group

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48(5):633-9, 2009 Mar 1 - Who cited this? | PubMed ID: 19202627 | Fulltext

Observation plans in longitudinal studies with time-varying treatments.

+ cite this

Hernán MA, McAdams M, McGrath N, Lanoy E, and Costagliola D

Statistical methods in medical research 18(1):27-52, 2009 Feb - Who cited this? | PubMed ID: 19036915 | Fulltext

Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.

+ cite this

+ View Abstract

Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C, Jarrousse B, Weiss L, Levy Y, Costagliola D, and FHDH ANRS CO4 ANRS CO141

Journal of acquired immune deficiency syndromes (1999) 50(2):206-14, 2009 Feb 1 - Who cited this? | PubMed ID: 19131886 | Fulltext

Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.

+ cite this

+ View Abstract

Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, Barin F, Costagliola D, Caumes E, Clauvel JP, Autran B, Musset L, and ALT ANRS CO15 Study Group

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 48(1):123-32, 2009 Jan 1 - Who cited this? | PubMed ID: 19035778 | Fulltext

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.

+ cite this

+ View Abstract

Guiguet M, Kendjo E, Carcelain G, Abgrall S, Mary-Krause M, Tattevin P, Yazdanpanah Y, Costagliola D, Duval X, and FHDH-ANRS CO4 Epidemiology Group

Antiviral therapy 14(3):451-7, 2009 - Who cited this? | PubMed ID: 19474479 | Fulltext

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

+ cite this

+ View Abstract

Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A,

(show remaining authors)

Retrovirology 6:49, 2009 - Who cited this? | PubMed ID: 19457244 | Fulltext

[Towards a vaccine for HIV infection: role of the gp41 envelope protein].

+ cite this

+ View Abstract

Debre P, Costagliola D, Legrand R, and Vieillard V

Bulletin de l'Academie nationale de medecine 193(1):127-36; discussion 137-8, 2009 Jan - Who cited this? | PubMed ID: 19718985 | Fulltext

Surgical management of cervical intraepithelial neoplasia in HIV-infected women.

+ cite this

+ View Abstract

Foulot H, Heard I, Potard V, Costagliola D, and Chapron C

European journal of obstetrics, gynecology, and reproductive biology 141(2):153-7, 2008 Dec - Who cited this? | PubMed ID: 18760524 | Fulltext

[In Process Citation].

+ cite this

Costagliola D

La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne 29 Suppl 3:S266-8, 2008 Dec - Who cited this? | PubMed ID: 18996629 | Fulltext

[Central nervous system demyelinating events and hepatitis B vaccine: A new episode of the never ending French saga!].

+ cite this

Costagliola D

Revue d'epidemiologie et de sante publique 56(6):379-81, 2008 Dec - Who cited this? | PubMed ID: 19019601 | Fulltext

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?.

+ cite this

+ View Abstract

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A,

(show remaining authors)

AIDS (London, England) 22(18):2481-92, 2008 Nov 30 - Who cited this? | PubMed ID: 19005271 | Fulltext

[A fighting life against aids.].

+ cite this

Costagliola D

Medecine sciences : M/S 24(11):979-80, 2008 Nov - Who cited this? | PubMed ID: 19038103 | Fulltext

[Cervical cancer: new testing strategies?].

+ cite this

Heard I and Costagliola D

Medecine sciences : M/S 24(11):977-8, 2008 Nov - Who cited this? | PubMed ID: 19038102 | Fulltext

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?.

+ cite this

+ View Abstract

Costagliola D, Damond F, Palmer P, Rouzioux C, and Brun-Vezinet F

AIDS (London, England) 22(15):2042, 2008 Oct 1 - Who cited this? | PubMed ID: 18784468 | Fulltext

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.

+ cite this

+ View Abstract

Valantin MA, Lanoy E, Bentata M, Kalmykova O, Boutekadjirt A, Allavena C, Rozenbaum W, Peytavin G, Amellal B, Calvez V, Costagliola D, Katlama C, and

HIV medicine 9(8):625-35, 2008 Oct - Who cited this? | PubMed ID: 18624724 | Fulltext

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.

+ cite this

+ View Abstract

Descamps D, Assoumou L, Masquelier B, Marcelin AG, Saidi S, Tamalet C, Cottalorda J, Plantier JC, Montes B, Izopet J, Peytavin G, Yerly S, Schneider V, Delaugerre C, Ferré V, Ruffault A,

(show remaining authors)

The Journal of antimicrobial chemotherapy 62(3):451, 2008 Sep - Who cited this? | PubMed ID: 18552344 | Fulltext

Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study.

+ cite this

+ View Abstract

Mouala C, Houzé S, Guiguet M, Abboud P, Pialoux G, Viget N, Costagliola D, and Matheron S

Journal of acquired immune deficiency syndromes (1999) 49(1):55-60, 2008 Sep 1 - Who cited this? | PubMed ID: 18667929 | Fulltext

Increased cardiovascular risk in HIV infection: drugs, virus and immunity.

+ cite this

Murphy R and Costagliola D

AIDS (London, England) 22(13):1625, 2008 Aug 20 - Who cited this? | PubMed ID: 18670222 | Fulltext

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The "Mortalité 2000 and 2005" Surveys (ANRS EN19 and Mortavic).

+ cite this

+ View Abstract

Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Salmon D, Cacoub P, Chêne G, and

Journal of acquired immune deficiency syndromes (1999) 48(5):590, 2008 Aug 15 - Who cited this? | PubMed ID: 18645512 | Fulltext

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

+ cite this

+ View Abstract

Duvivier C, Ghosn J, Assoumou L, Soulié C, Peytavin G, Calvez V, Algarté Génin M, Molina JM, Bouchaud O, Katlama C, Costagliola D, and

The Journal of antimicrobial chemotherapy, 2008 Jul 18 - Who cited this? | PubMed ID: 18641035 | Fulltext

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).

+ cite this

+ View Abstract

Autran B, Murphy RL, Costagliola D, Tubiana R, Clotet B, Gatell J, Staszewski S, Wincker N, Assoumou L, El-Habib R, Calvez V, Walker B, Katlama C, and

AIDS (London, England) 22(11):1313, 2008 Jul 11 - Who cited this? | PubMed ID: 18580611 | Fulltext

Initiatives for Developing and Comparing Genotype Interpretation Systems: External Validation of Existing Systems for Didanosine against Virological Response.

+ cite this

+ View Abstract

Assoumou L, Brun-Vézinet F, Cozzi-Lepri A, Kuritzkes D, Phillips A, Zolopa A, Degruttola V, Miller V, Costagliola D, and

The Journal of infectious diseases, 2008 Jul 3 - Who cited this? | PubMed ID: 18598191 | Fulltext

AIDS-Related Malignancies: State of the Art and Therapeutic Challenges.

+ cite this

+ View Abstract

Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, and Khayat D

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008 Jun 30 - Who cited this? | PubMed ID: 18591544 | Fulltext

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.

+ cite this

+ View Abstract

Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D, Mary-Krause M, and

AIDS (London, England) 22(10):1203, 2008 Jun 19 - Who cited this? | PubMed ID: 18525266 | Fulltext

Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.

+ cite this

+ View Abstract

Sagot-Lerolle N, Lamine A, Chaix ML, Boufassa F, Aboulker JP, Costagliola D, Goujard C, Paller C, Delfraissy JF, Lambotte O, and ANRS EP39 study

AIDS (London, England) 22(10):1125-9, 2008 Jun 19 - Who cited this? | PubMed ID: 18525257 | Fulltext

Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.

+ cite this

+ View Abstract

Masquelier B, Assoumou KL, Descamps D, Bocket L, Cottalorda J, Ruffault A, Marcelin AG, Morand-Joubert L, Tamalet C, Charpentier C, Peytavin G, Antoun Z, Brun-Vézinet F, Costagliola D, and ANRS Resistance Study Group

The Journal of antimicrobial chemotherapy 61(6):1362-8, 2008 Jun - Who cited this? | PubMed ID: 18390885 | Fulltext

National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation.

+ cite this

+ View Abstract

Delaugerre C, Flandre P, Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Schneider V, Yerly S, Legoff J, Morand-Joubert L, Chaix ML, Costagliola D, Calvez V, and NARS AC11 Resistance Group

Journal of medical virology 80(5):762-5, 2008 May - Who cited this? | PubMed ID: 18360911 | Fulltext

Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).

+ cite this

+ View Abstract

Guiguet M, Mary-Krause M, Ename B, Costagliola D, and Grabar S

Pharmacoepidemiology and drug safety 17(5):468-74, 2008 May - Who cited this? | PubMed ID: 18324608 | Fulltext

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.

+ cite this

+ View Abstract

Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P, Mahamat A, Rabaud C, Costagliola D, and

HIV medicine 9(4):246, 2008 Apr - Who cited this? | PubMed ID: 18366449 | Fulltext

Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.

+ cite this

+ View Abstract

Braibant M, Agut H, Rouzioux C, Costagliola D, Autran B, and Barin F

Journal of acquired immune deficiency syndromes (1999) 47(3):274-84, 2008 Mar 1 - Who cited this? | PubMed ID: 18197126 | Fulltext

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans.

+ cite this

+ View Abstract

Vogt A, Mahé B, Costagliola D, Bonduelle O, Hadam S, Schaefer G, Schaefer H, Katlama C, Sterry W, Autran B, Blume-Peytavi U, and Combadiere B

Journal of immunology (Baltimore, Md. : 1950) 180(3):1482-9, 2008 Feb 1 - Who cited this? | PubMed ID: 18209043 | Fulltext

Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy.

+ cite this

+ View Abstract

Selinger-Leneman H, Matheron S, Mahamat A, Moreau J, Costagliola D, Abgrall S, and Clinical Epidemiology Group of the French Hospital Database on HIV (ANRS CO4)

Journal of acquired immune deficiency syndromes (1999) 47(2):206-11, 2008 Feb 1 - Who cited this? | PubMed ID: 17971717 | Fulltext

Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.

+ cite this

+ View Abstract

Kousignian I, Abgrall S, Grabar S, Mahamat A, Teicher E, Rouveix E, Costagliola D, and Clinical Epidemiology Group of the French Hospital Database on HIV

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 46(2):296-304, 2008 Jan 15 - Who cited this? | PubMed ID: 18171266 | Fulltext

Nevirapine-associated toxicity in Niger.

+ cite this

Meyssonnier V, Costagliola D, and Caumes PE

HIV medicine 9(1):62-3, 2008 Jan - Who cited this? | PubMed ID: 18199174 | Fulltext

Search Google Scholar for Costagliola D

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!